title: Prospective study of Streptococcus milleri hepatic abscess.
abstract: Thirty-seven cases of microbiologically demonstrated pyogenic hepatic abscess were observed in a prospective study over a seven-year period. Biliary disease was the most common source of liver abscess (42%). Streptococcus milleri was the most common cause of hepatic abscess, accounting for 51% of the cases. Hepatic abscess is due to Streptococcus milleri clinically distinct from other forms of pyogenic liver abscess due to its torpid nature and the longer duration of its symptoms [42 vs. 11 days]. Occult hepatic abscess should be suspected if the blood culture is positive for Streptococcus milleri, since 28% of bacteremia cases due to Streptococcus milleri stem from hepatic abscesses. It is important to distinguish Streptococcus milleri from other members of the viridans streptococci group, which are frequently isolated as contaminants, but only exceptionally cause hepatic abscess. Unlike other pyogenic hepatic abscesses, those caused by Streptococcus milleri are frequently monomicrobial (79%). In the present study, empirical therapy of pyogenic hepatic abscess always included a drug that is effective against Streptococcus milleri.
authors.affiliation: Department of Internal Medicine, Hospital Xeral-Calde, Lugo, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Corredoira
authors.forename: E
authors.initials: E
authors.lastname: Casariego
authors.forename: C
authors.initials: C
authors.lastname: Moreno
authors.forename: L
authors.initials: L
authors.lastname: Villanueva
authors.lastname: López
authors.forename: J
authors.initials: J
authors.lastname: Varela
authors.forename: A
authors.initials: A
authors.lastname: Rodríguez
authors.forename: P
authors.initials: P
authors.lastname: Alonso
authors.forename: A
authors.initials: A
authors.lastname: Coira
mesh_terms: D005260:Female; D006801:Humans; D008100:Liver Abscess / Q000382:microbiology*; D008107:Liver Diseases / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013291:Streptococcus / Q000302:isolation & purification / Q000472:pathogenicity*